Organometallics
Article
5-PyH), 7.37 (s, 2H, NCHCHN), 6.79 (d, J = 14.8 Hz, 2H, CH2), 5.81
(d, J = 15.2 Hz, 2H, CH2), 3.17 (s, 6H, CH3). 13C NMR (100 MHz,
DMSO-d6): δ 157.64 (Ni−C), 155.09, 153.05, 141.42, 125.47, 125.31,
124.94, 123.58, 53.82, 36.08. Anal. Calcd for C20H22F12N6NiP2: C,
34.56; H, 3.19; N, 12.09. Found: C, 34.82; H, 3.19; N, 11.82. The cis
configuration of 3 was confirmed by NOE measurement.
1.78 (m, 2H, NCH2CH2CH2CH3), 1.33 (m, 2H, NCH2CH2CH2CH3),
0.92 (t, J = 6.8 Hz, 3H, NCH2CH2CH2CH3). Anal. Calcd for
C19H18ClF6N4PPd: C, 38.73; H, 3.08; N, 9.51. Found: C, 39.04; H,
3.10; N, 9.25.
[Pd(L3)2](PF6)2 (10). This complex was synthesized from 3 (35 mg,
0.05 mmol) and Pd(COD)Cl2 (14 mg, 0.05 mmol). Yield: 27 mg
(73%), white powder. 1H NMR (400 MHz, DMSO-d6): δ 8.29 (d, J =
5.2 Hz, 2H, 6-PyH), 8.24 (t, J = 7.6 Hz, 2H, 4-PyH), 7.96 (d, J = 7.6 Hz,
2H, 3-PyH), 7.76 (d, J = 1.6 Hz, 2H, NCHCHN), 7.62 (t, J = 6.4 Hz, 2H,
5-PyH), 7.49 (d, J = 1.6 Hz, 2H, NCHCHN), 6.17 (d, J = 14.8 Hz, 2H,
NCH2), 5.80 (d, J = 15.6 Hz, 2H, NCH2), 3.31 (s, 6H, NCH3). 13C
NMR (100 MHz, DMSO-d6): δ 156.05 (Pd−C), 154.28, 152.88,
142.00, 126.28, 125.91, 124.35, 123.64, 54.76, 37.04. Anal. Calcd for
C20H22F12N6P2Pd: C, 32.34; H, 2.99; N, 11.31. Found: C, 32.29; H,
3.10; N, 11.66.
[Ni(L4)2](PF6)2 (4).22a This complex was prepared from [HL4]-
(PF6) (77 mg, 0.20 mmol) and Raney nickel (120 mg). Yield: 63 mg
1
(77%), light yellow powder. H NMR (400 MHz, DMSO-d6): δ 8.97
(d, J = 4.8 Hz, 4H, 4,6-pyrimidinyl H), 8.32 (d, J = 5.2 Hz, 2H,
6-pyridyl H), 8.21 (t, J = 7.6 Hz, 2H, 4-pyridyl H), 8.04 (d, J = 7.6 Hz,
2H, 3-pyridyl H), 7.62−7.52 (m, 8H, NCHCHN + 5-pyridyl H +
5-pyrimidinyl H), 6.84 (d, J = 15.2 Hz, 2H, CH2), 6.04 (d, J = 14.8 Hz,
2H, CH2). Anal. Calcd for C26H22F12N10NiP2: C, 37.94; H, 2.69; N,
17.02. Found: C, 38.02; H, 2.69; N, 16.56.
[Pd(L4)2](PF6)2 (11).23c This complex was synthesized from 4 (42 mg,
0.05 mmol) and Pd(COD)Cl2 (14 mg, 0.05 mmol). Yield: 30 mg
(69%), white powder. 1H NMR (400 MHz, DMSO-d6): δ 8.86 (d, J =
4.8 Hz, 4H, 4,6-pyrimidinyl H), 8.53 (d, J = 5.6 Hz, 2H, 6-pyridyl H),
8.30 (t, J = 7.6 Hz, 2H, 4-pyridyl H), 8.08 (d, J = 7.6 Hz, 2H, 3-pyridyl
H), 7.72−7.56 (m, 8H, NCHCHN + 5-pyridyl H + 5-pyrimidinyl H),
6.23 (d, J = 14.4 Hz, 2H, NCH2), 6.00 (d, J = 14.8 Hz, 2H, NCH2).
Anal. Calcd for C26H22F12N10P2Pd: C, 35.86; H, 2.55; N, 16.08.
Found: C, 35.79; H, 2.59; N, 15.77.
[Pd(L5)Cl](PF6) (12). This complex was synthesized from 5 (43 mg,
0.05 mmol) and Pd(COD)Cl2 (29 mg, 0.10 mmol). Yield: 49 mg
(92%), white powder. 1H NMR (400 MHz, DMSO-d6): δ 9.43 (d, J =
5.6 Hz, 2H, 6-PyH), 8.24 (t, J = 7.6 Hz, 2H, 4-PyH), 7.89 (d, J =
7.6 Hz, 2H, 3-PyH), 7.70 (t, J = 7.2 Hz, 2H, 5-PyH), 7.64 (s, 2H,
NCHCHN), 5.72 (s, 4H, NCH2). 13C NMR (100 MHz, DMSO-d6):
δ 156.20 (Pd−C), 153.03, 149.19, 141.70, 127.01, 125.71, 122.13,
53.95. Anal. Calcd for C15H14ClF6N4PPd: C, 33.54; H, 2.63; N, 10.43.
Found: C, 33.67; H, 2.65; N, 10.25.
[Ni(L5)2](PF6)2 (5). This complex was prepared from [HL5](PF6)
(80 mg, 0.20 mmol) and Raney nickel (120 mg). Yield: 72 mg (85%),
1
yellow powder. H NMR (400 MHz, CD3CN): δ 8.69 (s, 2H), 8.00
(br, 2H), 7.92 (s, 2H), 7.74 (br, 4H), 7.31 (m, 6H), 7.23 (d, J = 7.6 Hz,
2H), 7.03 (s, 2H), 6.44 (d, J = 15.2 Hz, 2H, CH2), 5.49 (d, J =
14.8 Hz, 2H, CH2), 5.01 (d, J = 15.2 Hz, 2H, CH2), 4.38 (d, J = 15.6 Hz,
2H, CH2). 13C NMR (100 MHz, CD3CN): δ 158.88 (Ni-C), 154.70,
154.26, 152.25, 149.73, 140.85, 137.60, 125.33, 124.02, 123.67, 123.24,
122.57, 54.60, 54.24. Anal. Calcd for C30H28F12N8NiP2: C, 42.43; H,
3.32; N, 13.19. Found: C, 42.34; H, 3.25; N, 12.98.
[Ni(L6)2](PF6)2 (6). This complex was prepared from [HL6](PF6)
(122 mg, 0.20 mmol) and Raney nickel (120 mg). Yield: 117 mg
(92%), yellow powder. Anal. Calcd for C54H48F12N16NiP2: C, 51.08;
H, 3.81; N, 17.65. Found: C, 51.00; H, 3.91; N, 17.70. No satisfactory
NMR spectra of 6 were obtained, although we repeatedly measured in
different deuterated solvents.
[Ni(L7)](PF6)2 (7).22d This complex was prepared from [H2L7]-
(PF6)2 (124 mg, 0.20 mmol) and Raney nickel (120 mg). Yield: 108 mg
1
12 was also obtained from 24 (49 mg, 0.10 mmol) and
Pd(COD)Cl2 (29 mg, 0.10 mmol). Yield: 51 mg (95%).
(80%), greenish yellow powder. H NMR (400 MHz, DMSO-d6):
δ 8.58 (d, J = 5.6 Hz, 2H, 6-PyH), 8.22 (d, J = 7.6 Hz, 2H, 4-PyH),
7.86 (m, 6H, NCHCHN + 3-PyH), 7.58 (d, J = 6.4 Hz, 2H, 5-PyH),
6.42 (s, 2H, NCH2N), 5.80 (s, 4H, NCH2C). Anal. Calcd for C19H18-
F12N6NiP2: C, 33.61; H, 2.67; N, 12.38. Found: C, 33.73; H, 2.71; N,
12.12.
General Procedure for Carbene Transfer from Ni(II) to Pd(II),
Pt(II), Co(III), Ru(II), and Ni(II). Complexes 8−24 were synthesized
via the following route: a solution of NiII−NHC (0.05 mmol) in 2 mL
of CH3CN was treated with the corresponding equivalent of
Pd(COD)Cl2, Pt(COD)Cl2, CoCl2, [Ru(p-cycmene)Cl2]2, or Ni-
(PPh3)2Cl2. The mixture was allowed to react at 70 °C for 24 h. The
solution was filtered through Celite to remove the precipitate of NiCl2.
Then the filtrate was concentrated to ca. 1 mL. The compounds were
obtained by adding diethyl ether to the filtrate.
[Pd(L1)2(CH3CN)](PF6)2 (8). This complex was synthesized from 1
(41 mg, 0.05 mmol) and Pd(COD)Cl2 (14 mg, 0.05 mmol). Yield:
24 mg (63%), white powder. 1H NMR (400 MHz, DMSO-d6): δ 8.97
(d, J = 4.8 Hz, 1H, PyH), 8.58 (br, 1H, PyH), 8.56 (s, 1H, imidazolylidene
H), 8.42 (t, J = 7.6 Hz, 1H, PyH), 8.40 (s, 1H, imidazolylidene H),
8.19 (d, J = 8.0 Hz, 1H, PyH), 8.18 (s, 1H, imidazolylidene H), 8.07 (t,
J = 7.8 Hz, 1H, PyH), 7.88 (s, 1H, PyH), 7.73 (t, J = 6.0 Hz, 1H, PyH),
7.57 (s, 1H, imidazolylidene H), 7.52 (t, J = 6.0 Hz, 1H, PyH), 4.06 (s,
3H, CH3), 2.98 (s, 3H, CH3), 2.07 (s, 3H, CH3CN). 13C NMR (100
MHz, DMSO-d6): δ 160.29 (Pd−C), 156.92 (Pd−C), 151.43, 150.39,
149.53, 148.18, 143.99, 140.03, 125.88, 125.83, 124.71, 124.11, 122.78,
118.43, 117.92, 117.56, 112.73, 39.00, 36.51, 1.51. Anal. Calcd for
C24H27F12N9P2Pd ([Pd(L1)2(CH3CN)](PF6)2·2CH3CN): C, 34.40;
H, 3.25; N, 15.05. Found: C, 34.57; H, 3.32; N, 14.87.
[Pd(L6)Cl](PF6) (13). This complex was synthesized from 6 (64 mg,
0.05 mmol) and Pd(COD)Cl2 (29 mg, 0.10 mmol). Yield: 71 mg
(95%), white powder. 1H NMR (400 MHz, DMSO-d6): δ 8.63 (s, 2H,
5-triazole H), 7.93 (q, J = 2.8 Hz, 2H, 4,7-benzimidazole H), 7.55 (q,
J = 2.8 Hz, 2H, 5,6-benzimidazole H), 7.41−7.38 (m, 10H, PhH), 5.89
(s, 4H, NCH2), 5.82 (s, 4H, NCH2). 13C NMR (100 MHz, DMSO-
d6): δ 157.85 (Pd−C), 139.94, 134.67, 132.50, 129.30, 129.13, 128.75,
125.74, 125.22, 112.21, 55.28, 40.96. Anal. Calcd for C28H25.5ClF6-
N8.5PPd ([Pd(L6)Cl](PF6)·0.5CH3CN): C, 43.79; H, 3.35; N, 15.50.
Found: C,43.81; H, 3.46; N, 15.33.
13 was also obtained from 6 (64 mg, 0.05 mmol) and [Pd(η3-
C3H5)Cl]2 (18 mg, 0.05 mmol). Yield: 36 mg (50%).
[Pd(L7)](PF6)2 (14).22d This complex was synthesized from 7 (34 mg,
0.05 mmol) and Pd(COD)Cl2 (14 mg, 0.05 mmol). Yield: 30 mg
(82%), colorless powder. 1H NMR (400 MHz, DMSO-d6): δ 8.94 (d,
J = 5.2 Hz, 2H, 6-PyH), 8.32 (t, J = 7.6 Hz, 2H, 4-PyH), 7.97 (d, J =
7.6 Hz, 2H, 3-PyH), 7.85−7.80 (m, 6H, NCHCHN + 5-PyH), 6.50 (s,
2H, NCH2N), 5.74 (s, 4H, CCH2N). Anal. Calcd for C19H18F12-
N6P2Pd: C, 31.40; H, 2.50; N, 11.56. Found: C, 31.64; H, 2.50; N,
11.34.
[Pt(L2)Cl](PF6) (15).20c This complex was synthesized from 2 (47 mg,
0.05 mmol) and Pt(COD)Cl2 (38 mg, 0.10 mmol). Yield: 61 mg
(90%), yellow powder. 1H NMR (400 MHz, DMSO-d6): δ 8.98 (d, J =
8.8 Hz, 1H, phenanthroline H), 8.88 (d, J = 7.6 Hz, 1H, phenan-
throline H), 8.58 (d, J = 4.8 Hz, 1H, phenanthroline H), 8.47 (s, 1H,
NCHCHN), 8.31 (d, J = 8.4 Hz, 1H, phenanthroline H), 8.10 (br,
3H, phenanthroline H), 7.85 (s, 1H, NCHCHN), 4.25 (br, 2H,
NCH2CH2CH2CH3), 1.75 (m, 2H, NCH2CH2CH2CH3), 1.30 (m, 2H,
NCH2CH2CH2CH3), 0.90 (t, J = 7.2 Hz, 3H, NCH2CH2CH2CH3).
Anal. Calcd for C19H18ClF6N4PPt: C, 33.66; H, 2.68; N, 8.27. Found: C,
33.87; H, 2.69; N, 8.30.
[Pd(L2)Cl](PF6) (9).22b This complex was synthesized from 2 (47 mg,
0.05 mmol) and Pd(COD)Cl2 (28 mg, 0.10 mmol). Yield: 56 mg
(96%), yellow powder. 1H NMR (400 MHz, DMSO-d6): δ 9.05 (d, J =
8.8 Hz, 1H, phenanthroline H), 8.83 (d, J = 8.4 Hz, 1H, phenan-
throline H), 8.54 (s, 2H, NCHCHN + phenanthroline H), 8.39 (d, J =
8.8 Hz, 1H, phenanthroline H), 8.14 (s, 2H, phenanthroline H), 8.02
(dd, J = 8.0 Hz, J = 5.2 Hz, 1H, phenanthroline H), 7.82 (d, J = 2 Hz,
1H, NCHCHN), 4.36 (t, J = 6.8 Hz, 2H, NCH2CH2CH2CH3),
[Pt(L3)2](PF6)2 (16). This complex was synthesized from 3 (35 mg,
0.05 mmol) and Pt(COD)Cl2 (19 mg, 0.05 mmol). Yield: 26 mg
(63%, cis/trans = 0.8/1), white powder. 1H NMR (400 MHz, DMSO-
d6): δ 8.78 (d, J = 5.6 Hz, 2H, 6-PyHtrans), 8.39 (d, J = 5.6 Hz, 1.6H,
286
dx.doi.org/10.1021/om200881s | Organometallics 2012, 31, 282−288